CORONAVIRUS NEWS
Deployment of novel, cost-effective SARS-CoV-2 vaccine technology
Edinburgh-based biotechnology company Ingenza has made a significant breakthrough in the race to develop and manufacture a cost-effective vaccine against SARS-CoV-2, the virus responsible for the current pandemic and COVID-19 disease.
Reducing viral replication by aryl hydrocarbon receptor inhibition
Hercules Pharmaceuticals has announced the publication of promising preclinical in vivo trial results showing efficacy of its aryl hydrocarbon receptor (AhR) inhibitor HP163 against Zika virus infection and potentially against coronavirus.
Executive War College: ongoing virtual interactive sessions
Remarkable things are happening as laboratories and anatomical pathology groups answer the challenges of the SARS-CoV-2 pandemic and the need for greater numbers of virus tests. Despite shortages, laboratories are adding SARS-CoV-2 test capacity.
Molecular transport medium optimised for molecular testing
PrimeStore MTM is a molecular transport medium that provides a ‘snapshot’ in time of a sample by preserving and stabilising DNA and RNA. This means that samples can be collected, transported, and processed safely and efficiently.
Antibodies for SARS-CoV-2 virus detection
ViroStat has released a set of new monoclonal antibodies to the nucleocapsid of the SARS-CoV-2 virus. These five antibodies were selected from a group of 60 based on highest binding affinity and best ELISA pairing to detect native viral antigen.
Winter multiplex virus detection kit
Pro-Lab Diagnostics has announced that final-stage clinical trials are underway on the VIASURE Winter Multiplex CFR kit, which is expected to achieve CE certification by the end of August. Preliminary data show excellent performance characteristics.
Clinical validation of Adeptrix COVID-19 diagnostic test
Avacta Group, the developer of Affimer biotherapeutics and reagents, has begun work with the UK government’s CONDOR programme to evaluate and validate the high-throughput COVID-19 bead-assisted mass spectrometry (BAMS) assay developed with Adeptrix.
Molecular transport medium for dual SARS-CoV-2 and influenza sampling
EKF Diagnostics has added a novel viral transport media for the safe sample handling and testing of multiple infectious diseases from a single swab to its product range. PrimeStore MTM is a collection device that deactivates viruses.
Production of Platelia SARS-CoV-2 Total Ab test accelerated
Bio-Rad Laboratories is accelerating production of its Platelia SARS-CoV-2 Total Ab test, a blood-based immunoassay kit to help determine if an individual has developed antibodies to SARS-CoV-2, the virus associated with COVID-19 disease.
Prepare for a winter COVID-19 peak, warns Academy of Medical Sciences
The UK must prepare now for a potential new wave of coronavirus infections this winter that could be more serious than the first, says a new report from the Academy of Medical Sciences.
Novel sensors to detect SARS-CoV-2 coronavirus in waste water
Avacta Group, the developer of Affimer biotherapeutics and reagents, is collaborating with Integumen to evaluate recently generated Affimer reagents that bind the SARS-CoV-2 spike protein for the detection of the coronavirus in waste water.
Increasing efficiency of coronavirus sampling kit production
Xebios Diagnostics manufactures high-quality, ready-to-use culture media for microbiological diagnostic applications, and is using DOSE IT to aliquot viral transport medium (VTM) into sterile screw-capped tubes to meet market demand.
Equipment and reagents from Randox used in COVID-19 hospital in India
Randox Laboratories has installed an RX modena in a COVID-19 hospital in India, at the Netaji Subhash Chandra Bose Medical College in Madhya Pradesh state.
Rapid lateral-flow antibody test for SARS-CoV-2
Significant efforts are being made to protect public health and prevent local, regional or national spikes in SARS-CoV-2 cases. Antibody testing can determine population seroconversion and aid epidemiological and public health decisions.
Genes associated with high risk of severe COVID-19
Scientists from PrecisionLife have found 68 genes associated with risk of developing severe COVID-19 by using its proprietary AI-enabled precision medicine platform to analyse the genomes of 929 patients who had a severe response to SARS-CoV-2.
COVID-19: impact on the NTM patient
A free webinar on COVID-19 and the impact on the non-tuberculous mycobacteria (NTM) patient will be held on Wednesday, 8 July at 5.00 pm. Click on this news item for registration details.
Una Health and Fortress Diagnostics partner with the DHSC
Una Health, a distributor of in vitro diagnostics (IVDs), and Fortress Diagnostics, a provider of IVDs, are partnering with the Department of Health & Social Care in the Real Time Assessment of Community Transmission (REACT) study into COVID-19.
Use of digital pathology for remote diagnosis
Hamamatsu Photonics invites you to join a panel discussion with pathologist Dr Matthew Hanna and IT Manager Nikolas Stathonikos on Thursday 9 July 2020 (4.00 pm BST, 11.00 am EDT, 5.00 pm CET). Click on this item for the link to register.
Haematology biomarkers for COVID-19 assessment: an HORIBA white paper
HORIBA UK, Medical has published a white paper entitled ‘COVID-19 screening, prognosis and severity assessment with biomarkers for management of patients’. The paper provides a review of biomarkers that help in the assessment of COVID-19 severity.
Update on SARS-CoV-2 rapid antigen test development
Avacta Group has announced that the first Affimer-based rapid test strips to detect SARS-COV-2 spike protein have been evaluated by Avacta’s partners at Cytiva (formerly GE Healthcare Life Sciences) and show positive initial performance data.
Featured Supplier
R-Biopharm AG was founded in 1988 as a subsidiary of Röhm GmbH in Darmstadt, Germany. In 1991 it was taken over by the present managing director, Dr. Ralf M. Dreher. Since 1996 R-Biopharm’s quality management systems have been certified to the international standards ISO 9001 and in 2003 the company gained ISO 13485 quality management...
Upcoming Events
analytica 2022
Messe München, Germany
June 21-24, 2022
The Genomic and Microbiology Revolution: In Technology We Trust?
Royal Air Force Museum, Hendon, London
19 July 2022
Arab Lab Live 2022
Dubai International Convention & Exhibition Centre Dubai World Trade Centre - Trade Centre - Trade Centre 2 - Dubai - United Arab Emirates
24 - 26 October 2022
Lab Innovations 2022
Hall 2 NEC, Birmingham
2 & 3 November 2022
MEDICA 2022
Messe Düsseldorf D-40474 Düsseldorf, Stockumer Kirchstraße 61
14 - 17 November 2022
Access the latest issue of Pathology In Practice on your mobile device together with an archive of back issues.
Download the FREE Pathology In Practice app from your device's App store
